HOME > News > Announcements > 2024.3.29 Glac Biotech’s Totipro® PE0301 Wins NutraIngredients Award, Reinforcing Global Leadership in Postbiotics
2024.3.29 Glac Biotech’s Totipro® PE0301 Wins NutraIngredients Award, Reinforcing Global Leadership in Postbiotics
The spotlight shines once again on Glac Biotech. Following the international success of Totipro® PE0401, which won the prestigious NutraIngredients Microbiome Modulation Award, Glac proudly announced that its Totipro® PE0301 postbiotic has also earned a coveted NutraIngredients Award.
In a highly competitive global postbiotics market, these back-to-back honors reaffirm Glac Biotech’s role as a pioneer in functional raw materials, proving that its MIT-born Totipro® line has earned the recognition and trust of international experts.
Healthy Aging: The Global Opportunity
As societies worldwide confront aging populations, healthy aging has become one of the fastest-growing areas in the health industry. Probiotics and postbiotics are front and center, but competition is fierce.
Glac Biotech saw the opportunity early. By focusing on postbiotics (non-living probiotic derivatives), Glac developed ingredients that are not only safe and stable but also adaptable to countless formats. Beyond tablets and lozenges, Totipro® PE0301 has proven stable enough to be incorporated into baked goods, snacks, and even oral care products like toothpaste and mouthwash — dramatically expanding possibilities for global brands.
Why Upper Digestive Health Matters
The science behind PE0301 is anchored in a crucial health challenge: upper digestive and oral health decline with age, a risk factor tied not only to digestive disorders but also to cognitive conditions such as Alzheimer’s disease.
Studies show that the mouth hosts over 20 billion bacteria at any given time. Without proper balance, harmful microbes entering through the oral cavity can disrupt digestion, weaken immunity, and heighten disease risks. By strengthening the first line of defense in the oral and upper digestive tract, PE0301 supports both immediate digestive wellness and long-term brain health.
A Proven Formula, Backed by Research
Totipro® PE0301 is crafted from a unique trio of strains:
Tailored Solutions for Every Generation
As consumer awareness grows, younger populations are adopting the concept of early prevention — making postbiotics like PE0301 not just for seniors but for people of all ages.
Glac Biotech continues to lead this movement by combining science, innovation, and customization. By offering targeted solutions for different life stages, Glac empowers brands worldwide to meet consumer demand and ride the wave of healthy aging.
With Totipro® PE0301 now a NutraIngredients award-winner, Glac has once again demonstrated its ability to turn scientific excellence into products that redefine the future of health.
In a highly competitive global postbiotics market, these back-to-back honors reaffirm Glac Biotech’s role as a pioneer in functional raw materials, proving that its MIT-born Totipro® line has earned the recognition and trust of international experts.
Healthy Aging: The Global Opportunity
As societies worldwide confront aging populations, healthy aging has become one of the fastest-growing areas in the health industry. Probiotics and postbiotics are front and center, but competition is fierce.
Glac Biotech saw the opportunity early. By focusing on postbiotics (non-living probiotic derivatives), Glac developed ingredients that are not only safe and stable but also adaptable to countless formats. Beyond tablets and lozenges, Totipro® PE0301 has proven stable enough to be incorporated into baked goods, snacks, and even oral care products like toothpaste and mouthwash — dramatically expanding possibilities for global brands.
Why Upper Digestive Health Matters
The science behind PE0301 is anchored in a crucial health challenge: upper digestive and oral health decline with age, a risk factor tied not only to digestive disorders but also to cognitive conditions such as Alzheimer’s disease.
Studies show that the mouth hosts over 20 billion bacteria at any given time. Without proper balance, harmful microbes entering through the oral cavity can disrupt digestion, weaken immunity, and heighten disease risks. By strengthening the first line of defense in the oral and upper digestive tract, PE0301 supports both immediate digestive wellness and long-term brain health.
A Proven Formula, Backed by Research
Totipro® PE0301 is crafted from a unique trio of strains:
- Lactobacillus salivarius AP-32
- Lactobacillus plantarum LPL28
- Lactobacillus paracasei ET-66
Tailored Solutions for Every Generation
As consumer awareness grows, younger populations are adopting the concept of early prevention — making postbiotics like PE0301 not just for seniors but for people of all ages.
Glac Biotech continues to lead this movement by combining science, innovation, and customization. By offering targeted solutions for different life stages, Glac empowers brands worldwide to meet consumer demand and ride the wave of healthy aging.
With Totipro® PE0301 now a NutraIngredients award-winner, Glac has once again demonstrated its ability to turn scientific excellence into products that redefine the future of health.
-
Totipro® PE0401, the Postbiotic That Brings Health Within Reach — Making Daily Nutrition Simple and Joyful
-
2023.12.15 Glac Biotech’s PRONULIFE® LvUCare Wins Top Innovation Award from the Lactic Acid Bacteria Association
-
2023.3.23 Glac Biotech’s Flagship Probiotic CP-9 Reaches New Heights With Breakthrough Patent in Neonatal Jaundice Resea